Santhera Pharmaceuticals Holding AG
SIX:SANN
Santhera Pharmaceuticals Holding AG
Other Current Assets
Santhera Pharmaceuticals Holding AG
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Santhera Pharmaceuticals Holding AG
SIX:SANN
|
Other Current Assets
CHf321k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
AC Immune SA
NASDAQ:ACIU
|
Other Current Assets
CHf3.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Current Assets
$11.5m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Current Assets
CHf7.7m
|
CAGR 3-Years
42%
|
CAGR 5-Years
35%
|
CAGR 10-Years
4%
|
|
Idorsia Ltd
SIX:IDIA
|
Other Current Assets
CHf29.4m
|
CAGR 3-Years
28%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Current Assets
CHf513k
|
CAGR 3-Years
-43%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is Santhera Pharmaceuticals Holding AG's Other Current Assets?
Other Current Assets
321k
CHF
Based on the financial report for Dec 31, 2023, Santhera Pharmaceuticals Holding AG's Other Current Assets amounts to 321k CHF.
What is Santhera Pharmaceuticals Holding AG's Other Current Assets growth rate?
Other Current Assets CAGR 3Y
-2%
Over the last year, the Other Current Assets growth was -37%. The average annual Other Current Assets growth rates for Santhera Pharmaceuticals Holding AG have been -2% over the past three years .